Here are Top Medical stories of the day
Bicalutamide reduces hypertrichosis
A recent study has in the Journal of the American Academy of Dermatology has suggested that the addition of bicalutamide to oral minoxidil may improve minoxidil–induced hypertrichosis.
The combination of low-dose systemic minoxidil with antiandrogen therapy has been used for the treatment of female pattern hair loss (FPHL). Although minoxidil is shown to have a favorable safety profile, hypertrichosis occurs in up to 24% of patients. Bicalutamide is a pure, non-steroidal androgen receptor inhibitor that has been successfully used for FPHL treatment. Low-dose bicalutamide (25mg/daily) has also been used to treat moderate to severe hirsutism with significant efficacy.
For more details, check out the full story on the link below:
Bicalutamide May Reduce Minoxidil-Induced Hypertrichosis In Female Pattern Hair Loss: Study
T2D common in psychiatric patients
The prevalence of type 2 diabetes (T2D) is elevated in people with a psychiatric disorder compared with the general population, reveals a new research. The research was conducted by Nanna Lindekilde, Department of Psychology, University of Southern Denmark, Odense, Denmark, and colleagues.
The study has been published in the journal Diabetologia (the journal of the European Association for the Study of Diabetes (EASD)).
For more details, check out the full story on the link below:
Prevalence Of Type 2 Diabetes Elevated In Patients Of Common Psychiatric Disorders
Dental implant maintenance tied to peri- implantitis
Antiviral treatment reduces liver cancer progression
Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) is a disease with a high recurrence rate.
Researchers at the Osaka City University Graduate School of Medicine reported in a new cohort study that in patients of HCC after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.
For more details, check out the full story on the link below:
Thoracoscopy- safe surgical option
Esophageal atresia (EA) and tracheoesophageal fistula (TEF) is one of the most common congenital malformations of the esophagus, with an incidence of 1/2500–1/4500.
Recent study findings suggest that thoracoscopy surgery is safe and effective surgical option for patients with Gross type C Esophageal atresia (EA) and tracheoesophageal fistula (TEF). The study findings were published in the journal BMC Surgery on November 22, 2021.
For more details, check out the full story on the link below:
Thoracoscopy Safe Surgical Option For Gross Type C Esophageal Atresia: Study
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.